Charles Rosier, London UK | Partner at BTG Pactual
Charles Rosier’s Career
As an excellent investment banker, he has remained in the industry for 15 years now. Charles Rosier (Wordpress) was offered a job at Goldman Sachs (GMS) in the year 1999. He unhesitatingly accepted the offer and joined as their Managing Director. In August 2010, he became a member of BTG Pactual. In addition to this, he became a partner there. BTG Pactual is an investment bank situated in Latin America. Charles Rosier was accountable for the French-speaking markets of France, Belgium, as well as Quebec at UBS Warburg.
Positions Charles Rosier Held
Customer Focus, Long Term View, Global Thinking Presence, Meritocracy and Partnership and World-Class Governance were the major principles put in place by Charles Rosier whilst he was still involved with BTG Pactual. He worked in the role of Debt Capital Manager at SBC Warburg from 1997 to 2009. But, his first job was as an investment banker at Lehman Brothers. As a partner at BTG Pactual Bank, he got the chance to work with a notable institution with 30 years of experience, hiring over 2,500 workers in various areas in Latin America. BTG Pactual is an investment bank based in Latin America, with whom Charles Rosier was a partner for years.
Charles Rosier’s Education History
In order to attain further French certifications, Charles Rosier took two years of additional classes in preparation. He held many positions within the same sector and is now known as an experienced investment banker, particularly in large firms. He earned his first scientific Baccalaureate degree (which is same as A-levels in the UK). His profession began after Charles Rosier successfully completed his degree at ESCP Europe.
In 1996, Charles Rosier started his job at Lehman Brothers before joining UBS Warburg Investment Bank. A while later he became a member of Goldman Sachs Bank where he handled the finance department. He switched jobs several times while pursuing his career in the market as an investment banker. It was in the year 1991 that Charles Rosier completed his scientific degree at Fenelon Sainte-Marie.
Healthcare Projects of Charles Rosier
Being one of his healthcare projects, Charles Rosier invested in Mapreg, a pharmaceutical company led by Professor Etienne Baulieu. He generously invested capital in the company, which allowed them to perform research and give him specific profit-share. Charles Rosier was the major investor of the project, for which a drug was being tested to treat stroke that causes damage to the spinal cord. Baulieu and his colleagues found it challenging to develop a new drug due to lack of budget, which he addressed.